Demo Data from SIGIR 2026 / reviewers in the wild / expert
Alexandra B. Keenan
dblp:221/7063
· DBLP profile ↗
1ranked-venue papers
0as first author
0since 2021 · last 2018
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology
transcriptomics |
0.3 | 1 | 2018 | L1000FWD: fireworks visualization of drug-induced transcriptomic signatures · Bioinform. 2018 |
Bioinformatics and computational biology › drug discovery
drug mode of action analysis |
0.1 | 1 | 2018 | L1000FWD: fireworks visualization of drug-induced transcriptomic signatures · Bioinform. 2018 |
Methods — techniques the papers use, named apart from their topics
unsupervised clustering · 0.3similarity search · 0.3
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2018 | L1000FWD: fireworks visualization of drug-induced transcriptomic signaturesabstractMotivation: As part of the NIH Library of Integrated Network-based Cellular Signatures program, hundreds of thousands of transcriptomic signatures were generated with the L1000 technology, profiling the response of human cell lines to over 20 000 small molecule compounds. This effort is a promising approach toward revealing the mechanisms-of-action (MOA) for marketed drugs and other less studied potential therapeutic compounds. Results: L1000 fireworks display (L1000FWD) is a web application that provides interactive visualization of over 16 000 drug and small-molecule induced gene expression signatures. L1000FWD enables coloring of signatures by different attributes such as cell type, time point, concentration, as well as drug attributes such as MOA and clinical phase. Signature similarity search is implemented to enable the search for mimicking or opposing signatures given as input of up and down gene sets. Each point on the L1000FWD interactive map is linked to a signature landing page, which provides multifaceted knowledge from various sources about the signature and the drug. Notably such information includes most frequent diagnoses, co-prescribed drugs and age distribution of prescriptions as extracted from the Mount Sinai Health System electronic medical records. Overall, L1000FWD serves as a platform for identifying functions for novel small molecules using unsupervised clustering, as well as for exploring drug MOA. Availability and implementation: L1000FWD is freely accessible at: http://amp.pharm.mssm.edu/L1000FWD. Supplementary information: Supplementary data are available at Bioinformatics online. Zichen Wang 0002, Alexander Lachmann, Alexandra B. Keenan, Avi Ma'ayan |
Bioinform. | 3 |